ERLOTINIB
Generic: ERLOTINIB
Teva Pharmaceuticals USAManufacturer
ORALRoute
ERLOTINIB HYDROCHLORIDEActive Substance
2020-11-09Original Approval
ERLOTINIB is FDA application ANDA091059, sponsored by TEVA PHARMS USA INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DEATH
3,662 reports
2
DIARRHOEA
1,339 reports
3
RASH
1,316 reports
4
OFF LABEL USE
903 reports
5
MALIGNANT NEOPLASM PROGRESSION
890 reports
6
FATIGUE
717 reports
7
NAUSEA
694 reports
8
VOMITING
576 reports
9
DISEASE PROGRESSION
571 reports
10
DECREASED APPETITE
511 reports